Protagonist Therapeutics, Inc.PTGXNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$252.84M
↑ 782% above average
Average (9y)
$-37.07M
Historical baseline
Range
High:$252.84M
Low:$-131.37M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $252.84M | +370.0% |
| 2023 | $-93.65M | +28.7% |
| 2022 | $-131.37M | -4.4% |
| 2021 | $-125.84M | -95.1% |
| 2020 | $-64.52M | +19.9% |
| 2019 | $-80.52M | -90.5% |
| 2018 | $-42.27M | -11.5% |
| 2017 | $-37.90M | -16.0% |
| 2016 | $-32.67M | -120.8% |
| 2015 | $-14.79M | - |